T-cell receptor variable region genes in cutaneous T-cell lymphomas

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Cutaneous T-cell lymphomas (CTCL) are a group of malignant diseases affecting T cells in the skin.
• Understanding the T-cell receptor (TCR) repertoire in CTCL is crucial for diagnosing and understanding disease pathogenesis.
• TCR gene usage can indicate clonality and immune responses within tumors.

Purpose of the Study:

• To investigate the T-cell receptor beta (TCRBV) gene usage in skin biopsy samples from patients with various types of CTCL.
• To determine the presence and extent of clonal and non-clonal T-cell populations in CTCL.
• To assess the potential role of non-clonal T cells in the tumor microenvironment.

Main Methods:

• Analysis of TCRBV gene expression in 24 CTCL skin biopsy samples using semiquantitative reverse transcriptase coupled polymerase chain reaction (RT-PCR).
• A panel of 24 primers specific for TCRBV families was employed.
• Direct sequence analysis of PCR products was performed to identify clonal TCR transcripts.

Main Results:

• While some patients showed restricted TCRBV family expression, most expressed a wide range of families.
• Elevated expression of individual TCRBV families was observed in all patients compared to normal lymphocytes.
• Clonal TCR transcripts were identified in 18 out of 24 patients, with single or multiple T-cell clones detected.
• Non-clonal (reactive) T cells were found to be more numerous than anticipated in most CTCL samples.

Conclusions:

• Most CTCLs harbor a complex T-cell infiltrate comprising both clonal malignant T cells and a significant population of non-clonal, reactive T cells.
• The substantial presence of non-clonal T cells suggests their potential involvement in anti-tumor immune responses within the CTCL microenvironment.
• Further prospective and serial studies are warranted to fully elucidate the functional role of these reactive T cells in CTCL pathogenesis and immunity.